Diagnostic Classification of Interstitial Lung Disease in Clinical Practice.

Humans Lung Diseases, Interstitial / classification Practice Patterns, Physicians'
Diagnostic classification Interstitial lung disease Pulmonary fibrosis

Journal

Clinics in chest medicine
ISSN: 1557-8216
Titre abrégé: Clin Chest Med
Pays: United States
ID NLM: 7907612

Informations de publication

Date de publication:
06 2021
Historique:
entrez: 24 5 2021
pubmed: 25 5 2021
medline: 20 7 2021
Statut: ppublish

Résumé

Interstitial lung diseases (ILDs) are challenging to diagnose, requiring integration of multiple complex features that are often difficult to interpret. This article reviews a pragmatic approach to ILD diagnosis and classification, focusing on diagnostic tools and strategies that are used to separate different subtypes and identify the most appropriate management. We discuss the evolution of ILD classification and the contemporary approach that integrates routinely used diagnostic tools in a multidisciplinary discussion. We highlight the increasing importance of taking a multipronged approach to ILD classification that reflects the recent emphasis on disease behavior while also considering etiopathogenesis and morphologic features.

Identifiants

DOI: 10.1016/j.ccm.2021.03.002 PMID: 34024401
pubmed: 34024401
pii: S0272-5231(21)00029-0
doi: 10.1016/j.ccm.2021.03.002
pii:
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

251-261

Subventions

Organisme : NHLBI NIH HHS
ID : K23 HL146942
Pays : United States

Informations de copyright

Copyright © 2021 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Conflict of Interest Disclosures A. Adegunsoye is supported by a career development award from the National Heart, Lung, and Blood Institute (K23HL146942), and has received speaking and advisory board fees from Boehringer Ingelheim and grant funding for interstitial lung disease research from the Pulmonary Fibrosis Foundation. C.J. Ryerson is supported by a Health Professional Investigator Award from the Michael Smith Foundation for Health Research.

Auteurs

Ayodeji Adegunsoye (A)

Section of Pulmonary & Critical Care, The University of Chicago Medicine, 5841 South Maryland Avenue - MC6076 | M662, Chicago, IL 60637, USA.

Christopher J Ryerson (CJ)

Department of Medicine, University of British Columbia, Centre for Heart Lung Innovation, St. Paul's Hospital, Ward 8B, 1081 Burrard Street, Vancouver, British Columbia V6Z 1Y6, Canada. Electronic address: Chris.Ryerson@hli.ubc.ca.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Diagnostic Classification of Interstitial Lung...
questionsmedicales.fr › Maladies de l'appareil respiratoire › Maladies pulmonaires › Pneumopathies interstitielles › Diagnostic Classification of Interstitial Lung...
questionsmedicales.fr › Qualité, accès, évaluation des soins de santé › Prestations des soins de santé › Types de pratiques des médecins › Diagnostic Classification of Interstitial Lung...